A little bit volume came in this arvo. Don't think any leaks, more a realisation of how undervalued CHM currently is. Time line for 2024 has just been announced, most action will be by end of 2024. But if there was a leak then maybe a CHM 1101 deal, the ph1 results are just fantastic and as Shellbell pointed out, can compete with the other CoH trial results.
Anyway, still patience required but there is always a chance for an unexpected announcement. JC pointed again and again at the fact that CHM is now becoming interesting for big pharma. An USD100m / AUD 150m deal would be worth a sp of 20c. For the bigger forces that would be just pocket money but it would promote CHM into the next higher league. She is known very well in the CAR-T space, she helped to develop CD19 CAR-T, now developing CLTX and CD17 CAR-Ts. The ASX is currently valuing her work as NOTHING, but the US / Canadian players know her value and expertise.
GLTA
A little bit volume came in this arvo. Don't think any leaks,...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
